The effect of combined use of botulinum toxin type A and functional electric stimulation in the treatment of spastic drop foot after stroke: a preliminary investigation1 Catherine A Johnson, MA, SRP, Jane H Burridge, PhD, SRP, Paul W Strike, CStat, Duncan E Wood, PhD, CEng, Ian D Swain, PhD, CEng Archives of Physical Medicine and Rehabilitation Volume 85, Issue 6, Pages 902-909 (June 2004) DOI: 10.1016/j.apmr.2003.08.081
Fig 1 The ODFS III. Archives of Physical Medicine and Rehabilitation 2004 85, 902-909DOI: (10.1016/j.apmr.2003.08.081)
Fig 2 (A) Walking speed for the control group. (B) Nonstimulated walking speed for the treatment group. (C) Stimulated walking speed for the treatment group. Asterisks denote single outliers. Archives of Physical Medicine and Rehabilitation 2004 85, 902-909DOI: (10.1016/j.apmr.2003.08.081)
Fig 3 (A) The PCI of gait in the control group. (B) The PCI of nonstimulated walking in the treatment group. (C) The PCI of stimulated walking in the treatment group. Asterisks denote single outliers. Archives of Physical Medicine and Rehabilitation 2004 85, 902-909DOI: (10.1016/j.apmr.2003.08.081)
Fig 4 The RMA total score in (A) the control group and (B) the treatment group. Archives of Physical Medicine and Rehabilitation 2004 85, 902-909DOI: (10.1016/j.apmr.2003.08.081)
Fig 5 The SF-36 physical function dimension in (A) the control group and (B) the treatment group. Asterisk denotes single outlier. Archives of Physical Medicine and Rehabilitation 2004 85, 902-909DOI: (10.1016/j.apmr.2003.08.081)
Fig 6 The MAS of the ankle plantarflexors in (A) the control group and (B) the treatment group. Asterisk denotes single outlier. Archives of Physical Medicine and Rehabilitation 2004 85, 902-909DOI: (10.1016/j.apmr.2003.08.081)
Fig 7 The MAS of the quadriceps femoris in (A) the control group and (B) the treatment group. Archives of Physical Medicine and Rehabilitation 2004 85, 902-909DOI: (10.1016/j.apmr.2003.08.081)